Class II Medical Device

About SmartCemic

Pioneering the future of non-invasive health monitoring through quantum-enhanced spectral analysis technology.

46+
Biomarkers
±5%
Accuracy
<2s
Results

Our Company

A medical technology leader dedicated to revolutionizing personal health monitoring

Based in Phoenix, Arizona

NorCemic Inc. is a medical technology company dedicated to revolutionizing personal health monitoring. Founded with a vision to make advanced health diagnostics accessible to everyone, we develop cutting-edge non-invasive monitoring solutions.

Our flagship product, the SmartCemic QESA Pro (Quantum-Enhanced Spectral Analyzer), represents a breakthrough in biomarker monitoring technology. Using proprietary quantum-enhanced near-infrared spectroscopy, we enable accurate, pain-free monitoring of 46+ biomarkers including glucose, ketones, cholesterol, and comprehensive metabolic panels.

As a Class II Medical Device with FDA clearance pending, our technology is protected under US-PENDING-QESA-2024

SmartCemic QESA Pro

Next-Generation Health Monitoring

Non-Invasive
Real-Time
Pain-Free
46+
Biomarkers Monitored
±5%
Clinical Accuracy
<2s
Results Time
10
Skin Tone Calibration

Mission & Vision

Empowering individuals to take control of their health journey

Our Mission

To democratize health monitoring by providing accurate, affordable, and pain-free diagnostic tools that empower individuals to take control of their health journey.

Our Vision

A world where everyone has access to real-time health insights, enabling proactive healthcare management and early disease prevention across all communities.

Our Values

Innovation, inclusivity, accuracy, and accessibility drive everything we do. We believe healthcare technology should work for everyone, regardless of background.

Our Technology

Advanced optical sensing powered by AI analytics

The SmartCemic QESA Pro utilizes Quantum-Enhanced Spectral Analysis (QESA), a proprietary technology platform that delivers clinical-grade accuracy through advanced optical sensing and AI-powered analytics.

Multi-Wavelength NIR

16 precision wavelengths for comprehensive near-infrared spectroscopy analysis across multiple biomarker signatures.

Quantum Processing

Quantum-enhanced signal processing algorithms deliver superior accuracy and noise reduction in real-time.

AI/ML Analytics

Advanced machine learning models trained on diverse populations for equitable and precise results.

Skin Tone Calibration

Monk Skin Tone Scale (10-point) calibration ensures accurate readings across all skin types.

4-Stage Compensation

Real-time environmental compensation pipeline adjusts for temperature, humidity, and ambient conditions.

Certifications & Compliance

Meeting the highest standards in medical device regulation

FDA 510(k)
Pending Clearance
ISO 15197
Glucose Monitoring
HIPAA
Fully Compliant
CE Mark
Pending Approval
Class II Device
Medical Grade
FHIR R4
EHR Compatible

Our Journey

From founding to product launch

2022

Company Founded

NorCemic Inc. established in Phoenix, Arizona with a mission to revolutionize health monitoring.

2023

QESA Breakthrough

Quantum-enhanced spectral analysis technology achieves clinical accuracy milestones in lab trials.

2024

Patent & FDA

US patent filed and FDA 510(k) premarket notification submitted for SmartCemic QESA Pro.

2025

Product Launch

SmartCemic QESA Pro v3.2.0 released with 46+ biomarkers and comprehensive monitoring.

Leadership Team

The visionaries behind SmartCemic

AB

Ambima Buzhyason

Founder, President & CEO

PhD(c), MS, MBAHM - Visionary leader driving innovation in medical technology and non-invasive health monitoring.

CTO

Chief Technology Officer

Technology Leadership

Leading the development of quantum-enhanced spectroscopy and AI-driven health analytics.

CMO

Chief Medical Officer

Medical Leadership

Ensuring clinical accuracy and regulatory compliance across all SmartCemic products.

Interested in SmartCemic QESA Pro?

Contact us to learn more about our technology or partnership opportunities.

Contact Us